Komori
Fuji Pharma (4554) · InitiativeRestated

Strengthening the Management Control Framework, Internal Controls, and Compliance

First written in FY2017. 2 of 4 entries say "Advanced", first in FY2019. Latest entry: FY2022.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017AdvancedFY2019 – FY20202017: 12018: 020182019: 120192020: 120202021: 020212022: 12022
Same theme, other companies
Continuous Strengthening of Corporate Governance and Internal Control SystemsA theme 969 companies write about · 4 as a headwind · 1069 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 1075 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「In addition, to prepare for crisis events during normal operations, the permanent Risk Management Committee prepares response procedure sheets for crisis events and establishes response procedures for each of 17 types of crisis. Each year, the relevant departments conduct tabletop exercises for several of the 17 types of crisis, identify issues and take measures to address them.」

    Continues the risk management system, including maintaining response procedures for 17 types of crisis and conducting annual tabletop exercises.
  2. FY2020AdvancedAnnual report

    「In addition, the Risk Management Committee has prepared response procedure sheets for crisis events, established response procedures for each of 17 crises and communicated them throughout the company.」

    Describes the preparation and communication of response procedures for each of 17 types of crisis as a specific management and internal control measure.
  3. FY2019AdvancedAnnual report

    「In addition, to strengthen information security, we are working to reduce the risk of information leaks by developing an internal corporate network and setting expiration periods for the use of information storage media.」

    Describes the development of the internal network and the setting of expiration periods for information storage media as specific measures to strengthen the management system and IT infrastructure.
  4. FY2017First statedAnnual report

    「Strengthening the management system (strengthening the internal control system, ensuring compliance, establishing a risk management system and developing IT systems)」

    Lists internal controls, compliance, risk management and IT infrastructure as specific components of efforts to strengthen the management system.
Moved together

"Early development and launch of new drugs, biosimilars and value-added generics" moved the same way as this thread, in the same document, in 2 of its 4 moves.

222★123
  1. ★This thread
  2. 1Early development and launch of new drugs, biosimilars and value-added generics2×
  3. 2Expanding into global markets2×
  4. 3Investment in Production Facilities to Ensure High Quality and Stable Supply2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening the Management Control Framework, Internal Controls, and Compliance | Fuji Pharma Co.,Ltd. (4554) | Komori